Subthalamic NucleusCorpus StriatumDeep Brain StimulationParkinson DiseaseGlobus PallidusDopamineSubstantia NigraSubthalamus3,4-Dihydroxyphenylacetic AcidBasal GangliaAntiparkinson AgentsBrainThalamic NucleiReceptors, DopamineLevodopaElectrodes, ImplantedBeta RhythmBerberineStereotaxic TechniquesCorpus LuteumNeuronsHypokinesiaElectric Stimulation TherapyCorpus CallosumRats, Sprague-DawleyDyskinesiasCell NucleusOxidopamineNeural PathwaysRats, Inbred StrainsParkinsonian DisordersEntopeduncular NucleusDyskinesia, Drug-InducedAgenesis of Corpus CallosumDopamine AgentsThalamusTremorMuscle RigidityAction PotentialsMicroelectrodesMagnetic Resonance ImagingBiological ClocksElectric StimulationApomorphineFunctional LateralityReaction TimeBrain MappingMotor ActivityParkinson Disease, SecondaryNeostriatumNucleus AccumbensBehavior, AnimalCaudate NucleusNeuropsychological TestsMovementPedunculopontine Tegmental NucleusDopamine AgonistsMotor SkillsDysarthria1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridineContingent Negative VariationDopamine AntagonistsInhibition (Psychology)Pseudobulbar PalsySensation DisordersNeural InhibitionSpeech DisordersStereotyped BehaviorVentral Thalamic NucleiAnalysis of VariancePsychomotor PerformanceModels, NeurologicalSynaptic TransmissionImage Processing, Computer-AssistedCerebral CortexMotor CortexGABA AntagonistsNeurologic Examinationgamma-Aminobutyric AcidCortical SynchronizationElectroencephalographyNeurosurgical ProceduresMuscimolMesencephalonGait Disorders, NeurologicRats, WistarMedial Forebrain BundlePeriodicityElectrophysiologyVisible Human ProjectsMovement DisordersMicroinjectionsDenervationTime FactorsCorpora AllataDominance, CerebralTreatment OutcomeReceptors, Dopamine D2DystoniaSignal Processing, Computer-Assisted